# Regulation (EU) No 658/2014 of the European Parliament and of the Council of 15 May 2014 on fees payable to the European Medicines Agency for the conduct of pharmacovigilance activities in respect of medicinal products for human use (Text with EEA relevance) (revoked), Division 1: The fee for the assessment of each post-authorisation safety study shall be EUR 45 810 to be paid in two instalments as follows:

Extent: E+W+S+N.I.
Status: repealed

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

---
Source: https://www.legislation.gov.uk/eur/2014/658/annex/part/II/division/1 (the official version)
Page: https://openlegislation.uk/eu-regulation-2014-658/annex/part-II/division-1
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.